Principal Investigator
Thomas Linden
Department of Clinical Neuroscience and Rehabilitation,
Institute of Neuroscience and Physiology,
The Sahlgrenska Academy,
Gothenburg University,
Gothenburg, Sweden.
Thomas.Linden@neuro.gu.se
Summary
| Country | Sweden |
|---|---|
| Principal Investigator | Thomas Linden |
| Contact person (email) | Thomas.Linden@neuro.gu.se |
| Key publication/reference | Linden et al. Neuroepidemiol 2004;23:45-52 Linden et al. Stroke 2007;38:1860-1863 |
| Years in which study conducted | 1993-1994 (recruitment) |
| Sample | |
| Size | 249 |
| Population: Hospital/community | Hospital |
| Selection: consecutive/random | Consecutive |
| Admit with previous stroke? | Yes |
| Admit with TIA? | Yes |
| Age range | 70+ |
| Number of centres | 1 |
| Control group: number, population, selection | Other studies |
| Assessment | |
| Initial: Time and data collected/tests administered | CT, ECG, blood tests |
| Detailed | 3 weeks 3m, 12m: function, health-related QoL |
| Subsequent (follow-ups) | 18m: NΨ |
| Stroke-related data | Scandinavian Stroke Study score |
| Functional tests/data | Barthel Index, Sunnaas Index |
| Other medical tests/data | None |
| Neuropsychological tests | Ratings of cognitive symptoms and items from the Alzheimer’s Disease Assessment Scale |
| MRI scans, when and how many | No |
| PET scans | No |
| Psychiatric exams/diagnoses | Dementia |
| Intervention trialled? | 2:1 stroke unit or general ward |
CT=computed tomography scan, MedHx=medical history, VRF=vascular risk factors (hypertension, diabetes, atrial fibrillation, obesity, smoking etc.), NΨ=neuropsychological, TIA=transient ischemic attack, m=month, y=year
